As we move deeper into the Northern Hemisphere winter, multiple respiratory viruses are circulating concurrently, posing sustained challenges for health systems and surveillance.
The Pan American Health Organization (PAHO/WHO) has issued an epidemiological alert noting that seasonal influenza and respiratory syncytial virus (RSV) activity began earlier or with greater intensity than in past seasons, raising the possibility of simultaneous respiratory epidemics. This early activity was observed in data from late 2025 into early January 2026 and includes predominant circulation of influenza A(H3N2) and detection of other respiratory pathogens.
Respiratory viruses such as influenza, RSV and SARS-CoV-2 co-circulating can overlap in symptomatology and burden, making clinical and public-health responses more complex. For example, influenza and RSV both contribute significantly to hospital admissions among young children and older adults during winter.
Across Europe, the ECDC Communicable Disease Threats Report (week 3, Jan 2026) continues to highlight ongoing respiratory virus epidemiology along with monitoring for other threats such as measles and mpox — conditions that also affect vulnerable populations.
Key takeaways for epidemiologists and public-health teams:
Expect overlapping peaks of respiratory pathogens this winter — surveillance systems must detect and differentiate influenza, RSV, and SARS-CoV-2.
Prepare healthcare services for concurrent case loads, especially in pediatric and geriatric care.
Continue advocating for influenza and COVID-19 vaccination to reduce severe outcomes.
This situation demonstrates the perennial nature of respiratory virus surveillance — year after year, pathogens adapt and overlap, and robust monitoring remains essential.
Resources:
#Epidemiology #RespiratoryVirusSeason #Flu #RSV #COVID19 #PAHO #ECDC